The Patent Finder

Modulation of Transthyretin Expression

Isis Pharmaceuticals, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,697,860Diagnosis and Treatment of Disease
In force
 · Medium confidence
UsedRemaining
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 9,061,044Modulation of Transthyretin Expression
In force
 · Low confidence
Ionis Pharmaceuticals, Inc.In forceLow confidence
US 9,399,774Modulation of Transthyretin Expression
In force
 · Medium confidence
Ionis Pharmaceuticals, Inc.In forceMedium confidence
US 9,816,092Modulation of Transthyretin Expression
In force
 · Low confidence
Ionis Pharmaceuticals, Inc.In forceLow confidence
Application 13/098,303Modulation of Transthyretin Expression
Abandoned
Abandoned Nov 5, 2013
Isis Pharmaceuticals, Inc.AbandonedAbandoned Nov 5, 2013
Application 15/729,860Modulation of Transthyretin Expression
Abandoned
Abandoned Jan 15, 2019
Ionis Pharmaceuticals, Inc.AbandonedAbandoned Jan 15, 2019
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Isis Pharmaceuticals, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited